Latest 10-Q quarterly reports

VOC Energy Trust reported a decrease in distributable income for the first quarter of 2026 compared to the prior year, primarily driven by lower oil prices and reduced sales volumes.

Accelerant Holdings reported a 53% increase in total revenues for Q1 2026, driven by strong growth in direct commission income and net earned premiums, alongside strategic investments in its platform.

MV Oil Trust reports a significant decrease in distributable income for the first quarter of 2026, as the trust approaches its scheduled termination date of June 30, 2026.

Evolution Petroleum Corporation reported a net loss of $8.9 million for the third quarter ended March 31, 2026, impacted by lower commodity prices and derivative contract losses.

GrabAGun Digital Holdings Inc. reported an 11.1% increase in net revenues for the first quarter of 2026, reaching $25.9 million, but incurred a net loss of $1.8 million.

GRI Bio, Inc. (GRI) reported its first quarter 2026 financial results, highlighting progress in its clinical-stage biopharmaceutical development, particularly with its lead candidate GRI-0621 for fibrotic lung diseases.

Tri-County Financial Group reports a significant 75% increase in net income for Q1 2026, driven by higher net interest income and improved non-interest income.

CN Healthy Food Tech Group Corp. reported a 20.8% revenue increase in Q1 2026, yet experienced a net loss of $308,997 due to increased operating expenses and significant default interest.

Aptevo Therapeutics reported a net loss of $6.7 million for Q1 2026, with cash and cash equivalents decreasing to $14.5 million, while advancing its clinical pipeline.

Tango Therapeutics reports Q1 2026 results, detailing ongoing clinical trials, financial position, and strategic pipeline advancements.

Hasbro's Q1 2026 earnings surged on robust performance in its Wizards of the Coast and Digital Gaming segment, offsetting declines in Consumer Products and Entertainment.

Jack in the Box Inc. reported a decrease in net earnings for the second quarter of fiscal year 2026, with revenues impacted by lower same-store sales and a reduction in franchise operations.

Altimmune, Inc. details its first-quarter 2026 financial performance and progress in its late-stage clinical trials for liver disease treatments, including pemvidutide.

MacroGenics reports a 58% revenue increase in Q1 2026 driven by contract manufacturing and royalty revenue, alongside a 12% decrease in R&D expenses.

QuickLogic Corporation announced its first quarter 2026 financial results, showing a 17% year-over-year revenue increase driven by new product growth, while continuing to manage operating expenses.

North Haven Private Income Fund LLC reported a net decrease in members' capital of $10.2 million for the first quarter of 2026, primarily driven by net realized and unrealized losses on investments.

ECA Marcellus Trust I reports increased distributable income for Q1 2026 driven by higher natural gas prices and production volumes.

Acrivon Therapeutics reports Q1 2026 results, with continued investment in R&D and a focus on advancing its oncology pipeline, while managing cash runway.

Gulf Coast Ultra Deep Royalty Trust reports no royalty income for Q1 2026 due to the abandonment of its sole producing well, with administrative expenses covered by HOGA.

Medalist Diversified, Inc. reported a significant net income of $14.1 million for the first quarter of 2026, driven by substantial gains from property sales and a strategic shift away from REIT status.

AtlasClear Holdings, Inc. reported a 65% increase in revenue for the third quarter of fiscal year 2026, driven by new stock locate fees and participation in an at-the-market offering.

Digimarc Corporation announced its first quarter 2026 financial results, reporting a 19% decrease in total revenue driven by contract expirations and project completions.

Motorsport Games reported a significant increase in Q1 2026 revenue, driven by strong performance in its Gaming segment, particularly Le Mans Ultimate and RaceControl subscriptions.

Greenland Technologies Holding Corporation announced its first quarter 2026 financial results, showcasing a significant increase in revenue and net income driven by higher sales volumes.

Dyadic International's Q1 2026 report shows a significant 182.3% revenue increase driven by research and development, grant, and license/milestone revenues, alongside a narrowed net loss.

Equillium, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing a net loss of $5.3 million and a cash balance of $61.3 million, while advancing its EQ504 program.

Bionano Genomics reported a 4% increase in Q1 2026 revenue to $6.7 million, driven by instrument and consumable sales, but continues to face substantial doubt about its ability to continue as a going concern.

Applife Digital Solutions, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing revenue growth driven by platform enhancements and marketing initiatives, alongside significant operating losses and a substantial working capital deficit.

Tamboran Resources Corporation's Q3 2026 Form 10-Q filing details ongoing exploration and development activities, significant capital raises, and progress towards the Falcon Oil & Gas acquisition, while acknowledging going concern considerations.

Aquestive Therapeutics announces the termination of an executive employment agreement, with the executive transitioning to Corporate Secretary.